James Kelly Ganjei - Director at Inmune Bio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
INMB on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Kelly Ganjei since 11/24/2023

Holdings reported by James Kelly Ganjei for Inmune Bio, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Option (right to buy) 12.5K May 14, 2024 Direct Common Stock

Transactions reported by James Kelly Ganjei for Inmune Bio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.